Stifel Nicolaus Lowers Becton, Dickinson and Company (NYSE:BDX) Price Target to $224.00
Becton, Dickinson and Company (NYSE:BDX – Free Report) had its price objective decreased by Stifel Nicolaus from $280.00 to $224.00 in a research note published on Friday,Benzinga reports. Stifel Nicolaus currently has a buy rating on the medical instruments supplier’s stock. Other research analysts have also issued reports about the company. William Blair lowered Becton, […]
Becton, Dickinson and Company (NYSE:BDX – Free Report) had its price objective decreased by Stifel Nicolaus from $280.00 to $224.00 in a research note published on Friday,Benzinga reports. Stifel Nicolaus currently has a buy rating on the medical instruments supplier’s stock. Other research analysts have also issued reports about the company. William Blair lowered Becton, […]
